ARRAKIS THERAPEUTICS
Arrakis Therapeutics is a developer of a drug discovery platform intended to target RNA. The company's platform integrates leading-edge RNA bioinformatic and structural tools to produce a pipeline of rSMs to treat a range of disease including neurology, oncology and rare genetic diseases, enabling physicians to offer enhanced care.
ARRAKIS THERAPEUTICS
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2015-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.arrakistx.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
113 M USD
Technology used in webpage:
Domain Not Resolving Google Maps Cloudflare Hosting
Similar Organizations
Alterome Therapeutics
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.
Amylyx Pharmaceuticals
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Avalyn Pharma
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.
Mineralys Therapeutics
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Skye Bioscience
Skye Bioscience is a biopharmaceutical company focused on the discovery, development, and the commercialization.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
WuXi AppTec
WuXi AppTec investment in Series B - Arrakis Therapeutics
venBio Partners
venBio Partners investment in Series B - Arrakis Therapeutics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Arrakis Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - Arrakis Therapeutics
Henri Termeer
Henri Termeer investment in Series B - Arrakis Therapeutics
Omega Funds
Omega Funds investment in Series B - Arrakis Therapeutics
Advent Life Sciences
Advent Life Sciences investment in Series B - Arrakis Therapeutics
Nextech Invest
Nextech Invest investment in Series B - Arrakis Therapeutics
Canaan Partners
Canaan Partners investment in Series B - Arrakis Therapeutics
Celgene
Celgene investment in Series B - Arrakis Therapeutics
Official Site Inspections
http://www.arrakistx.com Semrush global rank: 13.21 M Semrush visits lastest month: 78
- Host name: 172.67.218.1
- IP address: 172.67.218.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Arrakis Therapeutics"
Arrakis Therapeutics - Wikipedia
Arrakis Therapeutics is a biopharmaceutical company developing oral medicines that target RNA to treat a range of diseases. [1] [2] The company is based in Waltham, Massachusetts, and …See details»
Arrakis Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Arrakis Therapeutics is a developer of a drug discovery platform intended to target RNA. The company's platform integrates leading-edge RNA bioinformatic and structural tools to produce a pipeline of …See details»
Arrakis Therapeutics - Overview, News & Similar companies
Mar 28, 2024 Arrakis Therapeutics to Participate in Upcoming May Investor Conferences WALTHAM, Mass.--(BUSINESS WIRE)--Arrakis Therapeutics, a biopharmaceutical company …See details»
Arrakis Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Arrakis Therapeutics, Inc. of Waltham, MA. Get the latest business insights from Dun & Bradstreet.See details»
Arrakis Therapeutics Overview | SignalHire Company Profile
Arrakis Therapeutics is a private company that has been in the industry for 9 years. The company currently specializes in the Pharmaceuticals, Biotechnology areas. The position of the CEO is …See details»
Arrakis Therapeutics - LinkedIn
Arrakis Therapeutics Pharmaceutical Manufacturing Waltham, MA 10,937 followers Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to millions of patients.See details»
Arrakis Therapeutics Announces New Scientific Advisory Board …
The company brings together scientific leaders in RNA structure, chemistry and biology, along with a highly experienced management team and the backing of leading life sciences …See details»
Arrakis Therapeutics - Company Profile - Tracxn
Dec 1, 2024 Arrakis Therapeutics - Provider of tools for the analysis of RNA structures. Raised a total funding of $113M over 2 rounds from 14 investors. Founded by Russell Petter, Alan …See details»
Arrakis Therapeutics - Craft
Arrakis Therapeutics has 5 employees across 2 locations and $113 m in total funding,. See insights on Arrakis Therapeutics including office locations, competitors, revenue, financials, …See details»
Arrakis Therapeutics Appoints Patrizio Renzetti as Vice President of ...
Waltham, MA – November 19, 2020 – Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, …See details»
Arrakis Therapeutics CEO and Key Executive Team | Craft.co
Arrakis Therapeutics's Chief Executive Officer, Director is Michael Gilman. Other executives include Katrine Bosley, Chairman; Jakob Loven, Director and 5 others. See the full leadership …See details»
Arrakis Therapeutics - VentureRadar
Similar Companies: Ribon Therapeutics USA Privately Held Ribon Therapeutics is a biotechnology company developing first-in-class therapeutics targeting novel enzyme families …See details»
Arrakis Therapeutics Company Overview, Contact Details ... - LeadIQ
Apr 18, 2019 Arrakistx hired Adrian Whitty as Scientific Advisory Board on Mar 23rd '21. Waltham, MA – March 23, 2021 — Arrakis Therapeutics, a biopharmaceutical company …See details»
Life on Arrakis - Arrakis Therapeutics
Defy the status quo, take the risks, lead with curiosity, believe in human kindness. At Arrakis, we dare to be extraordinary even when success isn’t a guarantee. We are leaping into the new …See details»
Arrakis Therapeutics Enters Strategic Collaboration and License ...
Apr 8, 2020 For more information, please visit www.arrakistx.com and engage with us on Twitter @ArrakisTx or on LinkedIn. Contacts. Investors: Will O’Connor 212-362-1200 …See details»
Working At Arrakis Therapeutics: Company Overview and Culture
Learn about working at Arrakis Therapeutics from employee reviews and detailed data on culture, salaries, demographics, management, financial, and more.See details»
Arrakis Therapeutics Staff Directory & Email Format - ContactOut
Explore Arrakis Therapeutics staff directory for direct access to contact details on 102 employees including email format, email address and phone numbers.See details»
Scientific Advisory Board - Arrakis Therapeutics
More specifically, he has identified new concepts in macromolecular folding, in RNA and protein catalysis, and in molecular evolution. He has also uncovered new principles of cellular RNA …See details»
Arrakis Therapeutics (@arrakistx) • Instagram photos and videos
280 Followers, 69 Following, 69 Posts - Arrakis Therapeutics (@arrakistx) on Instagram: "Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to millions of …See details»